Thursday, March 13, 2025 2:12:58 PM
They haven't even started the experiments.
They are "discussing" them. That takes time.
Then they have to form parameters to implement them. That takes time.
Then how long do the actual experiments take? More time.
Then after that, maybe they arrive at some kind of licensing agreement, more time.
They just keep kicking the can down the road, while all along the shareholder investment dwindles.
___
ABBIE licensing in 2026?
They are "discussing" them. That takes time.
Then they have to form parameters to implement them. That takes time.
Then how long do the actual experiments take? More time.
Then after that, maybe they arrive at some kind of licensing agreement, more time.
They just keep kicking the can down the road, while all along the shareholder investment dwindles.
___
ABBIE licensing in 2026?
Recent SHMN News
- SOHM Inc. Releases White Paper on ABBIE, a Cas9-Guided Integrase Enabling Stable Gene Integration and Creation of SKOV3-GYS1 Cell Line for Drug Discovery • ACCESS Newswire • 11/06/2025 02:30:00 PM
- SOHM Notes FDA's Evolving Gene-Editing Framework in Context of Ongoing ABBIE Platform Development • ACCESS Newswire • 11/04/2025 02:30:00 PM
